Pharmacokinetics and pharmacodynamics of a selective oral MEK1/2 inhibitor, pimasertib (MSC1936369B/AS703026), in patients with advanced Solid tumors

N. Houede; J. P. Delord; A. Awada; C. Lebbe; T. Lesimple; J. H. M. Schellens; S. Rottey; R. Kefford; O. von Richter; E. Raymond

doi:10.1016/S0959-8049(12)72397-3

Pharmacokinetics and pharmacodynamics of a selective oral MEK1/2 inhibitor, pimasertib (MSC1936369B/AS703026), in patients with advanced Solid tumors

N. Houede, J. P. Delord, A. Awada, C. Lebbe, T. Lesimple, J. H. M. Schellens, S. Rottey, R. Kefford, O. von Richter, E. Raymond

Research output: Contribution to journal › Meeting abstract › peer-review

Original language	English
Article number	600
Pages (from-to)	184-184
Number of pages	1
Journal	European Journal of Cancer
Volume	48
DOIs	https://doi.org/10.1016/S0959-8049(12)72397-3
Publication status	Published - Nov 2012
Externally published	Yes
Event	24th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics - Dublin, Ireland Duration: 6 Nov 2012 → 9 Nov 2012

Access to Document

10.1016/S0959-8049(12)72397-3

Cite this

Houede, N., Delord, J. P., Awada, A., Lebbe, C., Lesimple, T., Schellens, J. H. M., Rottey, S., Kefford, R., von Richter, O., & Raymond, E. (2012). Pharmacokinetics and pharmacodynamics of a selective oral MEK1/2 inhibitor, pimasertib (MSC1936369B/AS703026), in patients with advanced Solid tumors. European Journal of Cancer, 48, 184-184. Article 600. https://doi.org/10.1016/S0959-8049(12)72397-3

@article{a0f518dce29740ceaf426914d1347be8,

title = "Pharmacokinetics and pharmacodynamics of a selective oral MEK1/2 inhibitor, pimasertib (MSC1936369B/AS703026), in patients with advanced Solid tumors",

author = "N. Houede and Delord, {J. P.} and A. Awada and C. Lebbe and T. Lesimple and Schellens, {J. H. M.} and S. Rottey and R. Kefford and {von Richter}, O. and E. Raymond",

year = "2012",

month = nov,

doi = "10.1016/S0959-8049(12)72397-3",

language = "English",

volume = "48",

pages = "184--184",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "Elsevier",

note = "24th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics ; Conference date: 06-11-2012 Through 09-11-2012",

}

Houede, N, Delord, JP, Awada, A, Lebbe, C, Lesimple, T, Schellens, JHM, Rottey, S, Kefford, R, von Richter, O & Raymond, E 2012, 'Pharmacokinetics and pharmacodynamics of a selective oral MEK1/2 inhibitor, pimasertib (MSC1936369B/AS703026), in patients with advanced Solid tumors', European Journal of Cancer, vol. 48, 600, pp. 184-184. https://doi.org/10.1016/S0959-8049(12)72397-3

TY - JOUR

T1 - Pharmacokinetics and pharmacodynamics of a selective oral MEK1/2 inhibitor, pimasertib (MSC1936369B/AS703026), in patients with advanced Solid tumors

AU - Houede, N.

AU - Delord, J. P.

AU - Awada, A.

AU - Lebbe, C.

AU - Lesimple, T.

AU - Schellens, J. H. M.

AU - Rottey, S.

AU - Kefford, R.

AU - von Richter, O.

AU - Raymond, E.

PY - 2012/11

Y1 - 2012/11

U2 - 10.1016/S0959-8049(12)72397-3

DO - 10.1016/S0959-8049(12)72397-3

M3 - Meeting abstract

SN - 0959-8049

VL - 48

SP - 184

EP - 184

JO - European Journal of Cancer

JF - European Journal of Cancer

M1 - 600

T2 - 24th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics

Y2 - 6 November 2012 through 9 November 2012

ER -